Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Orgenesis Inc (ORGS)
NASDAQ:ORGS
Orgenesis (ORGS) Stock Price & Analysis
96 Followers
ORGS Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.25 - $1.50
Previous Close$0.48
Volume62.32K
Average Volume (3M)163.67K
Market Cap
$16.22M
Enterprise Value$74.12M
Total Cash (Recent Filing)$55.00K
Total Debt (Recent Filing)$21.75M
Price to Earnings (P/E)-0.5
Beta1.64
Next Earnings
May 09, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.90
Shares Outstanding31,877,063
10 Day Avg. Volume176,898
30 Day Avg. Volume163,672
Standard Deviation0.25
R-Squared0.05
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)14.18
Price to Sales (P/S)0.46
Price to Cash Flow (P/CF)-3.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.73
Enterprise Value/Gross Profit8.27
Enterprise Value/Ebitda-3.75
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Orgenesis News
Ownership Overview
30.90% Insiders
3.42% Mutual Funds
2.88% Other Institutional Investors
62.81% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ORGS FAQ
What was Orgenesis Inc’s price range in the past 12 months?
Orgenesis Inc lowest stock price was $0.25 and its highest was $1.50 in the past 12 months.
What is Orgenesis Inc’s market cap?
Currently, no data Available
When is Orgenesis Inc’s upcoming earnings report date?
Orgenesis Inc’s upcoming earnings report date is May 09, 2024 which is in 13 days.
How were Orgenesis Inc’s earnings last quarter?
Currently, no data Available
Is Orgenesis Inc overvalued?
According to Wall Street analysts Orgenesis Inc’s price is currently Overvalued.
Does Orgenesis Inc pay dividends?
Orgenesis Inc does not currently pay dividends.
What is Orgenesis Inc’s EPS estimate?
Orgenesis Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Orgenesis Inc have?
Orgenesis Inc has 34,149,780 shares outstanding.
What happened to Orgenesis Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Orgenesis Inc?
Currently, no hedge funds are holding shares in ORGS
---
Orgenesis Stock Smart Score
Company Description
Orgenesis Inc
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing and provision of technologies and services in the cell and gene therapy industry. It operates through the Contract Development and Manufacturing Organization (CDMO) and Cellular Therapy Business (CT) segments. The CDMO segment through MaSTherCell, comprises of comprehensive services from cell therapy development through cell therapy manufacturing for and companies that provide end-to-end solution. The CT segment includes a technology that demonstrates the capacity to induce a shift in the developmental fate of cells from the liver and trans-differentiating them into pancreatic beta cell-like insulin-producing cells. The company was founded on June 5, 2008 by Sarah Ferber and is headquartered in Germantown, MD.
---
ORGS Earnings Call
Q2 2023
0:00 / 0:00
---
ORGS Stock 12 Months Forecast
Average Price Target
―Technical Analysis
Adaptimmune Therapeutics
―
Clearside Biomedical
―
Intellia Therapeutics
―
Crispr Therapeutics AG
―
Best Analysts Covering ORGS
1 Year
1 Year Success Rate
0/0 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 11 months ago
Copying Unknown Analyst's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
---